Prostatis Group’s Northrop Grumman NOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.76M Sell
2,581
-150
-5% -$104K 0.45% 53
2025
Q4
$1.56M Buy
2,731
+375
+16% +$218K 0.37% 56
2025
Q3
$1.44M Buy
2,356
+385
+20% +$218K 0.36% 61
2025
Q2
$985K Sell
1,971
-329
-14% -$162K 0.28% 73
2025
Q1
$1.18M Sell
2,300
-15
-0.6% -$7.16K 0.37% 60
2024
Q4
$1.09M Buy
2,315
+436
+23% +$219K 0.32% 67
2024
Q3
$992K Sell
1,879
-518
-22% -$254K 0.32% 67
2024
Q2
$1.04M Buy
2,397
+476
+25% +$217K 0.37% 63
2024
Q1
$919K Sell
1,921
-205
-10% -$94.4K 0.35% 64
2023
Q4
$995K Sell
2,126
-42
-2% -$19.7K 0.42% 59
2023
Q3
$954K Sell
2,168
-719,624
-100% -$316M 0.47% 45
2023
Q2
$847K Buy
721,792
+720,591
+59,999% +$327M 0.39% 57
2023
Q1
$549K Buy
1,201
+225
+23% +$104K 0.29% 65
2022
Q4
$533K Buy
976
+31
+3% +$16.2K 0.32% 60
2022
Q3
$444K Buy
945
+1
+0.1% +$476 0.51% 38
2022
Q2
$452K Sell
944
-25
-3% -$11.5K 0.7% 16
2022
Q1
$433K Sell
969
-262
-21% -$108K 0.35% 44
2021
Q4
$476K Sell
1,231
-137
-10% -$51K 0.29% 53
2021
Q3
$493K Buy
1,368
+84
+7% +$30.4K 0.29% 58
2021
Q2
$467K Sell
1,284
-2,316
-64% -$834K 0.32% 58
2021
Q1
$1.16M Buy
3,600
+2,032
+130% +$613K 0.91% 27
2020
Q4
$478K Sell
1,568
-323
-17% -$98.8K 0.4% 54
2020
Q3
$597K Buy
1,891
+523
+38% +$171K 0.57% 41
2020
Q2
$421K Buy
1,368
+210
+18% +$68.9K 0.85% 40
2020
Q1
$350K Sell
1,158
-268
-19% -$93.2K 0.5% 32
2019
Q4
$491K Buy
+1,426
New +$501K 0.44% 43

Other funds holding NOC

Prostatis Group's NOC Position: Q1 2026 in Review

Prostatis Group reduced its Northrop Grumman (NOC) stake by 5.5% in Q1 2026, selling an estimated $104K and leaving 2,581 shares worth $1.76M. The position accounts for 0.45% of the portfolio, ranked #53.

Prostatis Group first reported a position in NOC in Q4 2019 and has held it in 26 quarters since. 1,875 funds tracked by Wall St. Rank hold NOC as of Q1 2026.

  • Prostatis Group held 2,581 shares of Northrop Grumman worth $1.76M as of Q1 2026.
  • Prostatis Group sold 150 Northrop Grumman shares in Q1 2026, an estimated $104K.
  • Northrop Grumman made up 0.45% of Prostatis Group's portfolio in Q1 2026, its #53 holding.
  • Prostatis Group first reported a position in Northrop Grumman in Q4 2019 and has held it in 26 quarters since.
  • 1,875 funds tracked by Wall St. Rank held Northrop Grumman as of Q1 2026.

Based on Prostatis Group's 13F filing for Q1 2026, filed 12 May 2026.